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Abstract 24 
The transmission of the urogenital serovars of Chlamydia trachomatis can be significantly 25 
influenced by vaginal gels. Hydroxyethyl cellulose is a commonly used gelling agent which 26 
can be found in vaginal gels. Hydroxyethyl cellulose showed a concentration dependent 27 
growth enhancing effect on Chlamydia trachomatis serovars D and E with a 26.1 fold 28 
maximal increase in vitro and a 2.57 fold increase in vivo. 29 
 30 
Main text 31 
 Chlamydia trachomatis (C. trachomatis) urogenital serovars D-K related infections 32 
cause diseases such as urethritis, cervicitis and pelvic inflammatory disease, while serovars 33 
L1-L2 are at the background of the less common disease lymphogranuloma venereum, a 34 
sexually transmitted infection, with systemic rather than local manifestations. Among 35 
urogenital Chlamydia, D and E serovars are highly prevalent (1)(2)(3). C. trachomatis 36 
urogenital infections are globally among the most common sexually transmitted infections. 37 
As an example, in 2016 1.598.354 C. trachomatis infections were reported in the US and the 38 
number of reported infections steadily increased from 2000 to 2016, reaching 497.3 cases 39 
per 100.000 population (4). The risk of Chlamydia transmission is greatly influenced by 40 
components of the cervicovaginal microenvironment including vaginal lactobacilli and 41 
indole-positive bacteria (5). Vaginal gels can be introduced into this microenvironment as 42 
lubricants or therapeutic gels. Vaginal gels are present during sexual intercourse and due to 43 
their spatial and temporal presence these gels may have a significant impact on the 44 
acquisition of Chlamydia infection and other sexually transmitted diseases. A major 45 
component of vaginal gels is the gelling agent itself. Hydroxyethyl cellulose (HEC) is a 46 
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commonly used gelling agent that can be found in lubricants and in therapeutic gels (6, 7). 47 
To elucidate the potential impact of HEC on chlamydial transmission, we tested the effect of 48 
HEC on the growth of C. trachomatis D and E serovars.  49 
HeLa 229 cells (ATCC) were placed into 96-well plates at a density of 4 x 104 cells/well 50 
in 100 µl of minimal essential medium (MEM) with Earle’s salts supplemented with 10% 51 
heat-inactivated fetal bovine serum, 2 mmol/l L-glutamine, 1x MEM vitamins, 1x non-52 
essential amino acids, 0.005% Na-pyruvate, 25 µg/ml gentamycin, 1 g/ml fungisone. The 53 
next day, the 90% confluent cells were infected with C. trachomatis D strain UW-3/CX (ATCC) 54 
and C. trachomatis serovar E strain DK20 (8). Before the infection, the chlamydial 55 
elementary bodies (EBs) were pre-incubated in HEC (European Pharmacopoeia 9.0 (9) 56 
quality, Molar Chemicals, Halásztelek, Hungary) dissolved in vaginal simulant buffer (NaCl 57 
3.51 g/l; KOH 1.40 g/l; Ca(OH)2 0.222 g/l; bovine serum albumin 0.018 g/l; lactic acid 2.00 g/l; 58 
acetic acid 1.00 g/l; glycerol 0.16 g/l; urea 0.4 g/l; glucose 5.0 g/l) (10) and as a control, 59 
vaginal simulant buffer alone for 1h 37oC, 5% CO2. The HEC solutions were prepared by 60 
dissolving 30 mg of the HEC polymers in 1 ml of physiological salt solution (0.9% w/v NaCl), 61 
followed by 2-fold dilutions in the vaginal simulant (the applied HEC concentration range 62 
was 1.5 – 0.023% w/v). The pH of the vaginal simulant was adjusted to a pH 4.2 or pH 7.0. 63 
The preincubated inocula were suspended in MEM supplemented with 0.5% w/v glucose, 64 
and the cells were infected at a multiplicity of infection of 8 for 60 min at 37oC, 5% CO2 65 
without centrifugation. After the infection, the cells were washed twice with PBS, and a 66 
culture medium containing 0.1 μg/ml cycloheximide was added. After a 48-hour incubation, 67 
the chlamydial genomic content was measured by quantitative PCR as described previously 68 
(11), the chlamydial inclusion count was measured by either standard manual or automatic 69 
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ChlamyCount immunofluorescent inclusion counting, as published earlier (12). Statistical 70 
evaluation of qPCR data was performed as described previously (11). All reagents were 71 
purchased from SIGMA, St. Louis, MO, USA, unless otherwise indicated. 72 
To better mimic the cervicovaginal environment, we used the vaginal simulant to dilute HEC 73 
and incubate C. trachomatis EBs. The pH of the vaginal simulant was adjusted to a pH4.2 or 74 
pH7 to mimic the normal and elevated pH of the cervicovaginal tract. Figure 1A shows a HEC 75 
concentration-dependent enhancement of chlamydial growth after the preincubation of C. 76 
trachomatis EBs in pH4.2 vaginal fluid measured by qPCR 48 hours post infection. The C. 77 
trachomatis serovar D maximum growth increase was 23.7 fold at the maximal 1.5% w/v 78 
HEC concentration, and a noticeable, but non-significant growth enhancement tendency 79 
could be detected up to a concentration of 0.188% w/v HEC. HEC at pH7 enhanced the 80 
chlamydial growth significantly with a 13.8 fold growth increase at a concentration of 1.5% 81 
w/v (Figure 1B). Interestingly, in the case of C. trachomatis serovar E, the maximum growth 82 
increase (22.25 and 26.1 fold at pH 4.2 and pH7 respectively) was observed at the second 83 
highest HEC concentration (0.75% w/v) at both pH 4.2 and pH7 indicating a different HEC-EB 84 
interaction between the serovars (Figure 1A-B). To validate the qPCR results, we performed 85 
the automatic Chlamydia inclusion counting using the ChlamyCount measuring system, at 86 
pH4.2 or pH7 at 1.5% w/v and 0.75% w/v HEC concentrations for serovar D and serovar E 87 
respectively. Inclusion counts showed similar, albeit lower growth enhancement than the 88 
chlamydial genome measurements by qPCR with a 5.9-6.5 fold increase for serovar D and 89 
5.95-6.05 fold increase for serovar E (Figure 1C). This difference is likely due to the fact, that 90 
ChlamyCount measures the chlamydial inclusion number, while qPCR measures the bacterial 91 
genome content of the inclusions.  92 
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To monitor the effect of HEC in vivo, 6-8 week old female BALB/c mice were treated s.c. with 93 
2.5 mg medroxyprogesterone acetate (Pfizer, Budapest, Hungary) 1 week before infection. 94 
Mice were inoculated intravaginally with 1x105 inclusion forming units (IFU) of C. 95 
trachomatis serovar D mixed with HEC (1.5% w/v) or without HEC and recoverable IFUs in 96 
cervicovaginal washing 3 days post infection were counted by using traditional 97 
immunofluorescence microscopy (12) (Figure 1D). All experiments were approved by the 98 
Animal Welfare Committee of the University of Szeged and conform to the Directive 99 
2010/63/EU of the European Parliament. The in vivo data also showed that HEC significantly 100 
increased the growth of C. trachomatis serovar D in the mouse genital tract, with a 2.57 fold 101 
enhancement 3 days post infection. It is important to note, that the chlamydial EBs were not 102 
preincubated with HEC before the infection, indicating an immediate growth enhancing 103 
effect of HEC in vivo. 104 
 Interestingly, our results are different from those of Sater et al. (13), who used the 105 
lymphogranuloma venereum strain C. trachomatis L2 and showed a concentration- and pH-106 
dependent inhibitory effect of HEC on chlamydial growth in vitro. However, there are 107 
important differences between the two studies, including the fact that we used a complex 108 
buffer which may mimic better the physicochemical properties of the vaginal fluid than the 109 
phosphate and acetate buffers used by Sater et al.. Moreover, we observed the growth 110 
enhancing effect at 1.5-0.75% w/v (15000-7500 g/ml) HEC concentrations, the 111 
concentrations that are common in the vaginal gels (7)(14), while Sater et al. used 112 
significantly lower HEC concentrations (2-200 g/ml).  Instead of serovar L2, we also used 113 
the more prevalent urogenital serovars D and E. While C. trachomatis D and L2 have minor 114 
genetic differences (15), there are several phenotypic differences between the two 115 
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serotypes. Previous studies showed that their early interactions with epithelial cells are 116 
different (16, 17), including the fact, that the centrifugation and dextrane pretreatment of 117 
host epithelial cells increased the infection efficacy of urogenital C. trachomatis serovars but 118 
had no impact on serovar L2. In addition, serovar E infection is heparin independent while 119 
serovar L2 infection exhibits a strong heparin dependency (18). Since probably HEC 120 
influences the early interactions between the EBs and the host cells, this effect may be 121 
different between the lymphogranuloma venereum and urogenital serovars.   122 
 Altogether, our study shows that vaginal gel components, such as the gelling agent 123 
HEC have a significant growth enhancing effect on two prevalent C. trachomatis urogenital 124 
serovars. This enhancing effect was observed in vitro over a wide pH range, at lower 125 
concentrations, and also in vivo. Since the growth enhancement can theoretically lower the 126 
minimal number of bacteria required for infection transmission, these results suggest the 127 
need for testing current and future vaginal gels to determine their growth enhancing effects 128 
on C. trachomatis and on other sexually transmitted pathogens.   129 
 130 
Funding 131 
The study was supported by the EFOP-3.6.1-16-2016-00008 European Union – Hungary 132 
grant.  133 
 134 
Conflict of interest 135 
The authors declare that they have no competing interests. 136 
 137 
References 138 
 o
n
 O
ctober 31, 2018 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
7 
 
1.  Bošnjak Z, Džijan S, Pavlinić D, Perić M, Ružman N, Križan IR, Lauc G, Antolović-Požgain A, 139 
Burazin J, Vuković D. 2012. Distribution of Chlamydia trachomatis serotypes in clinical 140 
urogenital samples from north-eastern Croatia. Curr Microbiol 64:552–560. 141 
2.  Wikström E, Surcel H-M, Merikukka M, Ohman H, Namujju PB, Tasanen K, Tiitinen A, 142 
Paavonen J, Lehtinen M. 2014. Changes over time in the Chlamydia trachomatis serotype 143 
distribution in Finnish women. Scand J Infect Dis 46:397–400. 144 
3.  Gao X, Chen X-S, Yin Y-P, Zhong M-Y, Shi M-Q, Wei W-H, Chen Q, Peeling RW, Mabey D. 145 
2007. Distribution study of Chlamydia trachomatis serovars among high-risk women in 146 
China performed using PCR-restriction fragment length polymorphism genotyping. J Clin 147 
Microbiol 45:1185–1189. 148 
4.   2016 Sexually Transmitted Diseases Surveillance. Centers for Disease Control and 149 
Prevention. 150 
5.  Aiyar A, Quayle AJ, Buckner LR, Sherchand SP, Chang TL, Zea AH, Martin DH, Belland RJ. 151 
2014. Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia 152 
trachomatis infection: role of vaginal co-infections. Front Cell Infect Microbiol 4:72. 153 
6.  Lai BE, Geonnotti AR, Desoto MG, Montefiori DC, Katz DF. 2010. Semi-solid gels function 154 
as physical barriers to human immunodeficiency virus transport in vitro. Antiviral Res 155 
88:143–151. 156 
7.  Mahalingam A, Simmons AP, Ugaonkar SR, Watson KM, Dezzutti CS, Rohan LC, Buckheit 157 
RW, Kiser PF. 2011. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione 158 
 o
n
 O
ctober 31, 2018 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
8 
 
analog with a dual mechanism of action against HIV-1. Antimicrob Agents Chemother 159 
55:1650–1660. 160 
8.  Eder T, Kobus S, Stallmann S, Stepanow S, Köhrer K, Hegemann JH, Rattei T. 2017. 161 
Genome sequencing of Chlamydia trachomatis serovars E and F reveals substantial 162 
genetic variation. Pathog Dis 75. 163 
9.   European Pharmacopoeia (Ph. Eur.) 9th Edition. 164 
10.  Owen DH, Katz DF. 1999. A vaginal fluid simulant. Contraception 59:91–95. 165 
11.  Eszik I, Lantos I, Önder K, Somogyvári F, Burián K, Endrész V, Virok DP. 2016. High 166 
dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of 167 
the infected cells. J Microbiol Methods 120:15–22. 168 
12.  Bogdanov A, Endrész V, Urbán S, Lantos I, Deák J, Burián K, Önder K, Ayaydin F, Balázs P, 169 
Virok DP. 2014. Application of DNA chip scanning technology for automatic detection of 170 
Chlamydia trachomatis and Chlamydia pneumoniae inclusions. Antimicrob Agents 171 
Chemother 58:405–413. 172 
13.  Sater AAA, Ojcius DM, Meyer MP. 2008. Susceptibility of Chlamydia trachomatis to the 173 
excipient hydroxyethyl cellulose: pH and concentration dependence of antimicrobial 174 
activity. Antimicrob Agents Chemother 52:2660–2662. 175 
14.  Gao Y, Yuan A, Chuchuen O, Ham A, Yang KH, Katz DF. 2015. Vaginal deployment and 176 
tenofovir delivery by microbicide gels. Drug Deliv Transl Res 5:279–294. 177 
 o
n
 O
ctober 31, 2018 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
9 
 
15.  Thomson NR, Holden MTG, Carder C, Lennard N, Lockey SJ, Marsh P, Skipp P, O’Connor 178 
CD, Goodhead I, Norbertzcak H, Harris B, Ormond D, Rance R, Quail MA, Parkhill J, 179 
Stephens RS, Clarke IN. 2008. Chlamydia trachomatis: genome sequence analysis of 180 
lymphogranuloma venereum isolates. Genome Res 18:161–171. 181 
16.  Davis CH, Wyrick PB. 1997. Differences in the association of Chlamydia trachomatis 182 
serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in 183 
vivo. Infect Immun 65:2914–2924. 184 
17.  Kuo CC, Grayston T. 1976. Interaction of Chlamydia trachomatis organisms and HeLa 229 185 
cells. Infect Immun 13:1103–1109. 186 
18.  Hegemann J H, Moelleken, K. 2012. Chlamydial adhesion and adhesinsIntracellular 187 
Pathogens I: Chlamydiales. ASM press, Washington DC. 188 
 189 
Figure Legend 190 
Figure 1. Impact of HEC on the growth of C. trachomatis serovars D and E in HeLa 229 cells in 191 
vitro at (A) pH4.2 and (B) pH7. Bacterial genome copy numbers were measured by direct 192 
qPCR (n=3). The qPCR data were validated by the ChlamyCount immunofluorescent 193 
automatic inclusion counting system (n=4). The images of the ChlamyCount processed wells 194 
and the counted inclusion numbers are shown (C). Recoverable C. trachomatis serovar D IFU 195 
in cervicovaginal swab samples 3 days post infection. Mice were infected intravaginally with 196 
C. trachomatis serovar D mixed with HEC (1.5% w/v) (n=7) or without HEC (n=5). Data are 197 
means +/- standard deviations. *: P < 0.05, **: P < 0.01 according to Student’s t-test. 198 
 199 
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